Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from NYSE

Stock Wars: Darden Restaurants Vs. Dave & Buster's

Benzinga’s weekly Stock Wars matches up two leaders in a major industry sector with the goal of determining which company is the better investment.

Benzinga

Mid-Morning Market Update: Markets Open Higher; Dow Gains 300 Points

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Wednesday.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2022

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Cathie Wood-Backed EV Maker Xpeng Clinches $1.14B Term Loan Deal To Fund Growth

Chinese electric vehicle maker XPeng, Inc. (NYSE: XPEV) has signed an agreement that would secure additional funding for the company to fuel growth.

Benzinga

Dana Q1 Earnings Tops Estimates; Cuts FY22 EPS Outlook

Dana Inc (NYSE:DAN) reported first-quarter FY22 sales growth of 9.6% year-on-year to $2.48 billion, beating the consensus of $2.24 billion. Light vehicle revenue fell 0.6% Y/Y, Commercial vehicles increased 32.7%, Off-Highway climbed 17.2%, and Power Technologies sales were flat. Adjusted EBITDA was $170 million versus $234 million last year. Selling, general and administrative…

Benzinga

Boston Scientific Jumps On Upbeat Q2, FY22 Guidance

Boston Scientific Corp (NYSE:BSX) generated net sales of $3.026 billion in Q1 FY22, beating the Wall Street estimate of $2.95 billion. Sales increased 10% Y/Y on a reported basis, 12.6% on an operational basis, and 9.7% on an organic basis, better than the management estimate of approximately 5% - 8%. The Company achieved…

Benzinga

Acutus Medical Stock Soars On Debt Refinancing, Divestiture Of Left-Heart Access Portfolio

Acutus Medical Inc (NASDAQ:AFIB) shares are skyrocketing on a commitment letter from Deerfield Management Company to refinance its existing debt with a new longer-term credit facility. The Company has also agreed to sell its left-heart access portfolio to Medtronic plc (NYSE:MDT). The combination of these two transactions, taken together with the Company’s recently completed restructuring,…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Recap: Gorman-Rupp Q1 Earnings

Gorman-Rupp (NYSE:GRC) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Benzinga

Where Universal Health Services Stands With Analysts

Analysts have provided the following ratings for Universal Health Services (NYSE:UHS) within the last quarter:

Benzinga

Where Capital One Financial Stands With Analysts

Within the last quarter, Capital One Financial (NYSE:COF) has observed the following analyst ratings:

Benzinga

Analyst Ratings for Roblox

Within the last quarter, Roblox (NYSE:RBLX) has observed the following analyst ratings:

Benzinga

What 5 Analyst Ratings Have To Say About Rush Street Interactive

Rush Street Interactive (NYSE:RSI) has observed the following analyst ratings within the last quarter:

Benzinga

Analyst Ratings for Ecolab

Ecolab (NYSE:ECL) has observed the following analyst ratings within the last quarter:

Benzinga

Where Carter's Stands With Analysts

Analysts have provided the following ratings for Carter's (NYSE:CRI) within the last quarter:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Expert Ratings for OGE Energy

Over the past 3 months, 4 analysts have published their opinion on OGE Energy (NYSE:OGE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Expert Ratings for Medical Properties Trust

Within the last quarter, Medical Properties Trust (NYSE:MPW) has observed the following analyst ratings:

Benzinga

Recap: PROG Holdings Q1 Earnings

PROG Holdings (NYSE:PRG) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

M/I Homes: Q1 Earnings Insights

M/I Homes (NYSE:MHO) reported its Q1 earnings results on Wednesday, April 27, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Recap: Oshkosh Q1 Earnings

Oshkosh (NYSE:OSK) reported its Q1 earnings results on Wednesday, April 27, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: GlaxoSmithKline Q1 Earnings

GlaxoSmithKline (NYSE:GSK) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Teck Resources Q1 Earnings

Teck Resources (NYSE:TECK) reported its Q1 earnings results on Wednesday, April 27, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

NetEase's Cloud Music Prosecutes Tencent Music

NetEase, Inc's (NASDAQ: NTES) Cloud Music unit prosecuted Tencent Music Entertainment Group (NYSE: TME) for alleged unfair competition and plagiarizing its app design, Reuters reports.

Benzinga

The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

Edwards Lifesciences Clocks 10% Top-Line Growth In Q1; Forecasts Lower Than Expected Q2 Sales

Edwards Lifesciences Corp (NYSE:EW) posted a Q1 adjusted EPS of $0.60, compared to $0.54 posted a year ago and beating the consensus of $0.57. Sales increased 10% to $1.34 billion (underlying 13%), beating the consensus of $1.31 billion. Transcatheter aortic valve replacement sales grew to $881 million, up 11%. Globally, the company's…

Benzinga

Jim Cramer Shares His Thoughts On Fluor, Tilray Brands And More

On CNBC’s "Mad Money Lightning Round," Jim Cramer said stocks, including Tilray Brands, Inc. (NASDAQ: TLRY) are impossible to own until the Fed legalizes cannabis.

1 … 371 372 373 374

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.